当前位置:
X-MOL 学术
›
Nat. Rev. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-12-21 , DOI: 10.1038/nrcardio.2017.208 Filip K. Swirski
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-12-21 , DOI: 10.1038/nrcardio.2017.208 Filip K. Swirski
Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial
中文翻译:
2017年的炎症和CVD:从克隆性造血到CANTOS试验
2017年的炎症和CVD:从克隆性造血到CANTOS试验
更新日期:2017-12-21
Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial, Published online: 21 December 2017; doi:10.1038/nrcardio.2017.208
In 2017, a cluster of papers have provided strong evidence in favour of the inflammation hypothesis in cardiovascular disease. From fundamental observations on clonal haematopoiesis to clinical evidence indicating that blocking an inflammatory cytokine mitigates heart disease, 2017 has been a watershed year.中文翻译:
2017年的炎症和CVD:从克隆性造血到CANTOS试验
2017年的炎症和CVD:从克隆性造血到CANTOS试验
2017年的炎症和CVD:从克隆性造血到CANTOS试验,在线发布:2017年12月21日; doi:10.1038 / nrcardio.2017.208
2017年,大量论文为心血管疾病的炎症假说提供了有力证据。从对克隆性造血功能的基础观察到表明阻断炎症性细胞因子可缓解心脏病的临床证据,2017年是分水岭。